This may be attributed to the fact that stimulation of naïve T cells with TGF-β in the absence of IL-4 can prompt the development of inducible Treg cells, which have been shown to alleviate experimental allergic asthma following specific immunotherapy and have also been observed in previous investigations of VIT7. This evidence concerns the gene TGFB1 and allergic asthma.